ID: ALA4063302

Max Phase: Preclinical

Molecular Formula: C9H10ClN3

Molecular Weight: 195.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  ClCCCn1nc2ccccc2n1

Standard InChI:  InChI=1S/C9H10ClN3/c10-6-3-7-13-11-8-4-1-2-5-9(8)12-13/h1-2,4-5H,3,6-7H2

Standard InChI Key:  PVWHVZAKXREYBM-UHFFFAOYSA-N

Associated Targets(Human)

SLC9A1 Tchem Sodium/hydrogen exchanger 1 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.65Molecular Weight (Monoisotopic): 195.0563AlogP: 2.06#Rotatable Bonds: 3
Polar Surface Area: 30.71Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.21CX LogD: 2.21
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.70Np Likeness Score: -1.23

References

1. Singh D, Silakari O..  (2017)  Sodium hydrogen exchanger inhibitory activity of benzotriazole derivatives.,  126  [PMID:27750152] [10.1016/j.ejmech.2016.10.005]

Source